Publication: An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
OXFORD UNIV PRESS